CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.02 ($10,166)
- 4 Open-market buy Director bought 28,934 shares at $0.98 ($28,422)
- 4 Open-market buy Chief Executive Officer bought 15,000 shares at $1.01 ($15,150)
- 4 Open-market buy Corporate Controller bought 7,548 shares at $0.99 ($7,468)
Page 18 of 25 · 494 filings